Why is graft-versus-host disease sometimes associated with leukoderma and fewer melanocytic naevi?
Feily
Amir
A
Namazi
Mohammad R
MR
D015415:Biomarkers / Q000378:metabolism; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D016207:Cytokines / Q000276:immunology*; D006086:Graft vs Host Disease / Q000150:complications / Q000276:immunology*; D006801:Humans; D017496:Hypopigmentation / Q000276:immunology*; D016867:Immunocompromised Host; D007375:Interleukin-1 / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D009508:Nevus, Pigmented / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000276:immunology; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D015415:Biomarkers; D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha